financetom
Business
financetom
/
Business
/
China's Trustar raises $1 bln for vehicle that holds McDonald's China stake, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China's Trustar raises $1 bln for vehicle that holds McDonald's China stake, sources say
Nov 21, 2024 6:28 PM

*

Qatar Investment Authority committed biggest amount to

become

anchor investor

*

Other investors in fund include Chinese sovereign fund

CIC,

yuan-denominated investors

*

McDonald's China says goal to reach 10,000 restaurants

remains

unchanged

By Kane Wu

HONG KONG, Nov 21 (Reuters) - Trustar Capital has raised

$1 billion for a continuation fund that will hold the Chinese

private equity firm's controlling stake in McDonald Corp's

operations in mainland China and Hong Kong, two sources

with knowledge of the matter said.

A continuation fund is a new vehicle created by a private

equity (PE) firm to transfer holdings of existing investments.

The concept has gained traction in Asia in recent years as PE

firms' exit from companies via IPOs became challenging.

Sovereign wealth fund Qatar Investment Authority (QIA) has

committed the biggest amount to become the anchor investor in

Trustar's continuation fund, said the sources, who declined to

be named as the information is confidential.

Other investors in the $1-billion continuation fund included

Chinese sovereign fund China Investment Corp (CIC) and a number

of Chinese yuan-denominated investors, they added.

McDonald's China said the firm was pleased to see Trustar

has increased its investment in McDonald's China, based on "a

strong confidence in the growth prospects" of the Chinese

economy, as well as the company's development potential.

The company said its goal to reach 10,000 restaurants

remains unchanged. "The transaction further simplifies the

ownership structure ... with the support of our shareholders, we

will continue to drive the future growth of our business."

Formerly known as CITIC Capital, Trustar transferred its

equity interest in McDonald's China from its private equity fund

into the continuation fund, which will hold 52% of the

operations, said the sources.

Trustar didn't immediately respond to a Reuters request

for comment. CIC and QIA declined to comment.

The capital raised for the continuation fund will be used to

provide an exit to some investors in Trustar's private equity

fund, known as limited partners, said the two sources and

another person with knowledge of the matter.

In 2017, Chicago-based McDonald's sold an 80% stake in its

Chinese operations to a group that included CITIC Ltd ( CTPCF ),

its investment arm CITIC Capital, and Carlyle Group ( CG ) for

up to $2.1 billion.

The two CITIC ( CTPCF ) entities owned 52% jointly in that deal.

CITIC Ltd ( CTPCF ) said last month it had agreed to sell its 19.23%

stake in the company to a unit of Trustar for $430.3 million,

fully exiting the business at a valuation of around $2.2

billion.

In comparison, Carlyle announced a year ago the sale of its

28% stake back to McDonald's, which valued the China business at

$6 billion, Reuters reported at the time. After the repurchase,

McDonald's raised its stake to 48% in the China business.

The closure of the continuation fund valued McDonald's

mainland China and Hong Kong operations at the same level as the

CITIC's ( CTPCF ) deal last month, said the two sources.

Trustar's closing of the continuation fund comes as PE firms

and their investors look for alternative liquidity options amid

volatile market conditions, geopolitical tensions and China's

tightening of IPOs.

Investors in the continuation fund will also commit capital

to a new private equity fund Trustar is raising, said the

sources.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newcore Gold Files Technical Report for Updated Preliminary Economic Assessment for Enchi Gold Project in Ghana
Newcore Gold Files Technical Report for Updated Preliminary Economic Assessment for Enchi Gold Project in Ghana
Jun 10, 2024
06:46 AM EDT, 06/10/2024 (MT Newswires) -- Newcore Gold ( NCAUF ) said on Friday that it filed the technical report for the independent, updated preliminary economic assessment for the company's 100%-owned Enchi Gold Project in Ghana. The company reported an average annual gold production of 121,839 ounces and peak gold production in year six of 155,188 ounces. Also, the...
Norway wealth fund to vote against Musk's $56 billion Tesla pay package
Norway wealth fund to vote against Musk's $56 billion Tesla pay package
Jun 10, 2024
OSLO (Reuters) -Norway's $1.7 trillion sovereign wealth fund said on Saturday it will vote against ratifying Tesla CEO Elon Musk's $56 billion pay package, which is up for a shareholder vote next week, after a Delaware judge invalidated it earlier this year. The fund is Tesla's eighth-biggest shareholder, according to LSEG data. Musk's pay, the largest for a chief executive...
Oculis Sees Favorable Topline Results in Study of Potential Dye-Eye Disease Treatment
Oculis Sees Favorable Topline Results in Study of Potential Dye-Eye Disease Treatment
Jun 10, 2024
06:44 AM EDT, 06/10/2024 (MT Newswires) -- Oculis Holding (OCS) said Monday it had detected favorable topline results from a phase 2b trial of licaminlimab for the treatment of patients with dry-eye disease. The 122-patient study showed treatment effects favoring licaminlimab in multiple sign endpoints accepted by the US Food and Drug Administration. ...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Moderna COVID/flu combo vaccine superior to separate shots in trial
Jun 10, 2024
June 10 (Reuters) - Moderna ( MRNA ) said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage trial. In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional...
Copyright 2023-2026 - www.financetom.com All Rights Reserved